期刊文献+

地中海贫血骨髓移植中造血干细胞状态及功能的研究 被引量:3

Analysis of State and Function of Hematopoietic Stem Cell in Thalassemia Bone Marrow Transplantation
下载PDF
导出
摘要 通过分析预处理前造血干细胞(hematopoietic stem cell,HSCs)的状态(数量、在细胞周期的分布、活性氧的状态、凋亡情况、DNA损伤程度、DNA损伤相关酶活性)和功能(体外的集落检测、NOD/SCID小鼠体内造血重建功能),提出用地贫患者HSCs评价其骨髓移植危险因素和等级,以及根据预处理过程中HSCs根除情况调整预处理方案是未来地贫骨髓移植发展的两大趋势. Thalassemia is a common hematologic disorder inherited through single -gene mutation. At present, al- logeneic hematopoietic stem cells (HSCs) transplantation is the only rational therapeutic modality for the eradica- tion of thalassemia major. The promising strategies in bone marrow transplantation (BMT) of thalassemia major are ( 1 ) a method evaluating the risk factors and classes of BMT is established through analyzing the state ( the number of long- term HSCs, the percentage of quiescent HSCs and proliferative status of HSCs in the cell cycle, reactive oxygen species, apoptosis, oxidative DNA poietic reconstitution capacity of HSCs in ment; (2) preparatory regimen of BMT is transplant treatment. damage, DNA repair enzymes) and functions ( colony assay, the hemato- recipient mice of NOD/SCID) of HSCs before the pre - transplant treat- adjusted based on the elimination of HSCs during the process of pre -transplant treatment.
作者 李续娥 李峰
出处 《华南师范大学学报(自然科学版)》 CAS 北大核心 2013年第1期10-13,共4页 Journal of South China Normal University(Natural Science Edition)
基金 美国国家卫生研究院基金项目(R01 HL076712)
关键词 地中海贫血 骨髓移植 造血干细胞 预处理方案 危险等级 thalassemia bone marrow transplantation hematopoietic stem cell preparatory regimens risk class
  • 相关文献

参考文献18

  • 1PERSONS D A. Targeting p - thalassaemia[ J ].Nature,2010,467:227 -228. 被引量:1
  • 2朱鸿斌,何勤.地中海贫血发病机制的研究进展[J].医学综述,2011,17(11):1616-1618. 被引量:12
  • 3李春富.造血干细胞移植治疗重型β地中海贫血[J].中国小儿血液与肿瘤杂志,2009,14(4):147-150. 被引量:4
  • 4ANTONELLA I, JAVID G, PIETRO S, et al. Progress inhematopoietic stem cell transplantation as allogeneic cel-lulai* gene therapy in thalassemia [ J ].Ann N Y AcadSci, 2010, 1202:149-154. 被引量:1
  • 5ISSARAGRISIL S. Stem cell transplantation for thalasse-mia[ J].Int J Hematol, 2002,76:307 -309. 被引量:1
  • 6FANG J P,XU L H. Hematopoietic stem cell transplan-tation for children with thalassemia major in China [ J ].Pediatr Blood Cancer, 2010,55 ; 1062 - 1065. 被引量:1
  • 7朱志刚,李庆山,王汉平,王顺清,毛平.非清髓性外周血造血干细胞移植治疗重型β-地中海贫血1例[J].中国组织工程研究与临床康复,2008,12(3):501-504. 被引量:4
  • 8LI X, SIPPLE J, PANG QS, et al. Salidroside stimulatesDNA repair enzyme Parp -1 activity in mouse HSC main-tenance [J].Blood, 2012,119: 4162-4173. 被引量:1
  • 9DU W, LI X,SIPPLE J, et al. Overexpression of IL -3 Rot on CD34 + CD38 - stem cells defines leukemia - in-itiating cells in Fanconi anemia AML[ J].Blood, 2011,117: 4243 -4252. 被引量:1
  • 10CHEUNG Y F,SHING C, MO Y. Circulating CD133 +VEGFR2+ and CD34+ VEGFR2+ cells and arterialfunction in patients with beta - thalassaemia major[ J].Ann Hematol, 2011,8:1301 -1308. 被引量:1

二级参考文献75

共引文献18

同被引文献14

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部